Your browser doesn't support javascript.
loading
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia.
Liebman, Howard A; Saleh, Mansoor N; Bussel, James B; Negrea, O George; Horne, Heather; Wegener, William A; Goldenberg, David M.
Afiliação
  • Liebman HA; Internal Medicine, Jane Anne Nohl Division of Hematology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA liebman@usc.edu dmg.gscancer@att.net.
  • Saleh MN; Georgia Cancer Specialists, Atlanta, GA, USA.
  • Bussel JB; Platelet Disorders Center, Division of Pediatric Hematology-Oncology, New York Presbyterian Hospital, NY, USA.
  • Negrea OG; Low Country Cancer Care Assoc., Savannah, GA, USA.
  • Horne H; Immunomedics, Inc., Morris Plains, NJ, USA.
  • Wegener WA; Immunomedics, Inc., Morris Plains, NJ, USA.
  • Goldenberg DM; Immunomedics, Inc., Morris Plains, NJ, USA liebman@usc.edu dmg.gscancer@att.net.
Haematologica ; 101(11): 1327-1332, 2016 11.
Article em En | MEDLINE | ID: mdl-27515248

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Anticorpos Monoclonais Humanizados Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Anticorpos Monoclonais Humanizados Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2016 Tipo de documento: Article